Allscripts Acquires Medifor: Will Offer Physician Driven Patient Education

Software Enables Physicians to 'Prescribe' A Patient Care Plan Over the Internet

Port Townsend, WA and Chicago, IL – April 13, 2000 — Allscripts, Inc. (NASDAQ: MDRX), the leading provider of electronic prescribing, medication management, and physician productivity solutions, announced today the acquisition of Medifor Inc., the leader in Internet delivered patient education. The transaction is valued at $33 million in stock.

The merger brings together Allscripts’ TouchScript® Personal Prescriber™, the premier electronic prescribing solution at the point-of-care, and Medifor’s PATIENT ED® system, a highly innovative software solution that improves patient outcomes through dissemination of customized instructions, illustrations, and personalized patient education material at the point-of-care and over the Internet. Physicians can access over 1,000 templates for common medical conditions. Medifor currently has more than 3,000 physician subscribers at 500 locations nationwide while TouchScript is currently being used by more than 2,000 physicians nationwide.

"Together, our software will enable physicians, with just a few touches of the screen, to create a prescription on their Personal Prescriber and to ‘prescribe’ a personalized, secure webpage for each patient. Each webpage will contain a confidential care plan and also include links to other medically appropriate information and resources," commented Glen Tullman, Chief Executive Officer of Allscripts, Inc. "The PATIENT ED system builds upon the physician-patient relationship by leveraging precious physician time with education and communication tools and extends their relationship with patients beyond the office walls."

Medifor's solution enhances the quality of treatment decisions, empowers the provider as an educator, makes patients full, collaborative partners in their own care and helps reduce physician workload through affordable, easy-to-implement information technologies. The system also saves physicians time because all instructions can be automatically added to the patient’s chart. All of this functionality is provided via the Internet to allow for easy to use, easy to access information.

"We are excited to be joining the Allscripts’ team. Our two solutions complement each other perfectly and focus on the most valuable point in the healthcare continuum: the physician-patient encounter in the exam room", said J. Peter Geerlofs, MD, President and Chief Executive Officer of Medifor Inc. and newly appointed Chief Medical Officer of Allscripts, Inc. "We also share a belief that physicians are most attracted to clinical tools that can enhance patient satisfaction and outcomes, be implemented rapidly, and save time, benefits available today using both of our tools."

About Medifor
Medifor, Inc. publishes clinical software designed to help physicians more effectively communicate with patients, both at the point of care and via the Internet. Medifor’s PATIENT ED® system is a unique knowledge engine that instantly presents a physician with the information necessary to create appropriate treatment plans. It then generates a document to help the patient better understand and comply with the plan, as well as providing patient access to expanded on-line medical information prescribed by the physician and a dedicated, private e-mail system for enhancing physician-patient communication. Medifor is also a leading publisher of clinical reference CD-ROMs such as The New England Journal of Medicine, American Family Physician, PediaStat, and The Merck Manual. Medifor is headquartered in Port Townsend, Washington and provides products and services to more than 8,000 physicians worldwide. Visit Medifor on the Web at medifor.com. PATIENT ED®, Just-Right, Just-in-Time Information®, Medifor Direct™, and Prescribe the Web™ are trademarks of Medifor Inc.

About Allscripts
Allscripts, Inc. is the leading provider of innovative point-of-care medication management and productivity enhancing solutions designed to meet the needs of physician practices and managed care payers and plans. The Company's TouchScript software provides easy-to-use electronic prescribing that reduces medication errors and uses the Internet to route transactions to local retail, Internet and mail order pharmacies and managed care organizations. The Personal Prescriber is based on the Hewlett-Packard (NYSE: HWP) Jornada 600 Series hand-held PC hardware and runs on Microsoft’s Windows CE operating system. The Company also provides a number of Internet-based patient compliance and physician education services such as its e-Detailing products, as well as e-commerce applications. Through its recent acquisition of MasterChart, Allscripts also markets the Practical Portable, the premier hand-held digital dictation solution for physicians. Strategic partners include IMS Health (NYSE: RX), the world’s largest supplier of information to the pharmaceutical industry, and PlanetRx.com (NASDAQ: PLRX), a leading Internet healthcare destination for commerce, content, and community. Allscripts is headquartered in Libertyville, IL, and provides services to over 10,000 physicians at 3,000 sites across the U.S. Visit Allscripts on the Web at allscripts.com. Allscripts, TouchScript, TouchScript.Net, Personal Prescriber and 3Touch are trademarks of Allscripts, Inc.

This announcement contains forward-looking statements that involve risks and uncertainties. These forward-looking statements are developed by combining currently available information with Allscripts’ beliefs and assumptions. These statements often contain words like believe, expect, anticipate, intend, contemplate, seek, plan, estimate or similar expressions. Forward-looking statements do not guarantee future performance. These statements are made under the protection afforded them by Section 21E of the Securities Exchange Act of 1934. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts’ actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see its Registration Statement on Form S-1 (No. 333-78431), as amended July 23,1999.

PATIENT ED® and Medifor Direct^SM are trademarks of Medifor, Inc.

For more information, contact:

Steven Schwartz, Vice President-Sales & Marketing
Medifor, Inc.
info@medifor.com